Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

Positive phase II data for PL-9643 in patients with moderate to severe dry eye disease

Dec. 16, 2020

Gene therapy in one eye improves vision in both

Dec. 16, 2020

Phase III KESTREL study of Beovu in DME meets primary endpoint

Dec. 15, 2020

Aerpio announces phase II data on razuprotafib in glaucoma

Dec. 14, 2020

FDA accepts IND application for MicroLine as treatment of presbyopia

Dec. 4, 2020

Positive data from GLP toxicology study of EYP-1901

Dec. 4, 2020

Enrollment begins in registrational trial of Nyxol to reverse pharmacologically induced mydriasis

Nov. 20, 2020

Innovent presents phase I data on IBI-302 for neovascular AMD

Nov. 17, 2020

Positive 12-month data for AAV-RPGR in X-linked retinitis pigmentosa

Nov. 17, 2020

Medshine Discovery divulges KLKB1 inhibitors

Nov. 13, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 28, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...